GSK Plc: Gepotidacin Shows Non-inferiority To Nitrofurantoin In EAGLE-2 And EAGLE-3 Phase III Trials
17/4 08:18
(RTTNews) - GSK plc (GSK, GSK.L) reported positive results from the EAGLE-2 and EAGLE-3 phase III trials for gepotidacin, an investigational oral antibiotic for uncomplicated urinary tract infections in female adults and adolescents. In the EAGLE-2 and EAGLE-3 phase III trials, g...